Serum SFRP5 is significantly higher in patients with acute ST segment elevation myocardial infarction (STEMI) compared to patients without CHD, and is negatively correlated with the levels of high-sensitivity cardiac troponin I and C-reactive protein (156). The gene discussed is SFRP5; the disease is coronary artery disorder.